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ascending, transverse and descending aorta and ductus arteriosus (PDA).
Morphomatric measurements were obtained and indexed to body sutiace
area for aortic annulus and root, ascending and transverse aorta, aortic isth-
mue, mitral valve area, LV long-axis, LV volume and mass. The degree of
endocerdial fibroelastoeis (EFE) and which ventricle formed the apex of the
hearl wera also determined. Results:28 infants (maan age 1 * 0.6 daye,
mean weight 3.8 + 0.8 kg) with CAS were evaluated. 19 had a 2 ventricle
repair initially attempted and 9 had a Norvmd operation. The hemodynamic
factors associated with survival after a 2 ventricle repair were predominant
ortotel antegrade flow in the ascending and transverse aorta (ps 0.01 and p
< 0.05). Aortic valve gradient, mitral valve inflow, and flow in the descending
aorta and PDA were unrelated to outcome. The anatomic factors associated
with aurvival after’ 2 ventricle repair included the, indexed aortic annulus,
aortic met, ascending aorta and LV long-axis length (p <0.0002, 0.003,
0.006 and 0.01). A lesser degree of EFE and an apex forming LV were also
associated with survival (p <0.002 and p < 0.05). The LV volume, mass,
ejection fraction and mitral valve area ware not related to outcome following
2 ventricle repair.
Cone/usbns.’Determination of a oneversus2ventricle repair isacomplex
issue in infants with CAS. In addition to established anatomic predictors,
additional hemodynamic information on the direction flow in the aorta may
help define candidates for the Norwood operation.
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n7514 TheFateofthe Neo-PulmonaryValveAftertheArterialSwitchOperationin Neonatee
S. Nogi, B.W. McCrindle, C. Boutin, W.G. Williams, R.M. Freedom,
L.N. Benson. TheHoepita/forSic/rChildren,UniversifyofToronto,Toronto,
Canada
Todetermine the incidence and risk factom for acquired stenoeiaof theneo-
pulmonaty valve (neo-PV) after the neonatal arterial switch operation (ASO),
we reviewed the pre-operative and follow-up echos of 138of 266 consecutive
ASO patients for whom adequate foilow-up and images wera avaiiable.
Diagposes wereTGA4VS in 91, TGIVVSD in 39, TGANSDICOA in 5 and
DORV in 1 patient. No patient had neo-PV abnormalities before ASO. During
follow-up (median 16 m, range <1 m to 90 m), 32 patients (24Yo)developed
supravalvar PS, 15 (11%)with associated neo-PV stenoais. Intewention was
required in 11 patients, 10 with neo-PV atenoeis. Kaplan-Meier estimates
of freedom from intervention were 94% (9570Cl, 9070 to 99%) at 1 year,
and 79% (95% Cl, 64% to 94’7.) at 5 yeare. Echo measurements pre-ASO
and at latest follow-up or intervention were normalized for BSA se z scores
based on non-linear regression equatione derived from normals. The neo-
PV annulus pre-ASO was significantly larger (p < 0.03) in thoee who did not
develop neo-PV stenosis (zPV 0.76+ 0.93; p <0.03 from normal) vs. those
who did (zPV 0.15 & 1.10; p = 0.60). At follow-up, the neo-PV annulus had
decreaeed significantly in size in both groups, but more (p < 0.03) in those
with neo-PV stenosis (–1.50 + 1.34; p < 0,0007) than without (-0.46 +
1.71; p < 0.003). Patients with neo-PV stenosis developed significant neo-
PV annular hypoplaeia (zPV -1.34 +0.91; p < 0.0001) while patients without
neo-PV stenosis continued to have significantly larger valves than normal
(zPV 0.26+ 1.40; p c 0.03). Neo-PV stenosis after ASO is not uncommon
and is associated with growth faiiure of the valve annulus with significant
supravalvar PS.
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\751-5] ReducingA0ftlcRegur9itationfrom~,~~f’ete
SubaorticStenosis;ModifiedSurgicalMethodand
Reaulta
A.J. Party, J.P. Kovalchin, K. Suda, J. Wudel, N.H. Silverman, V.M, Reddy,
F.L. Hanley. The Universityof Ca/ifomiaSanFrancisco,SanFrancisco,CA,
USA
Diacrete subaotiicstenosis often causes aortic regurgitation (AR) which then
precipitates surgery. Conventional surgical resaction successfully relieves
the obstruction, but its impact on the AR is limited. Conventionally the mem-
brane is simply resected, with or without a myotomy or myectomy, but this
does not deal with the usual extension of the membrane which encroaches
onto thevelva Ieaflats.We modified this approach by identifying the full extent
of the mambrane and excising it completely, peeling it off the undersurface
of the leaflets and thinning them. In addition an extensive myomectomy
was performed. LVOT obstruction and AR were assessed on pre and p@t-
operetive echocerdiogrems by2 independent obeervers.The AR was graded
on a ecale of O-4 (O= none, 4 = severe) by assessing the width and depth of
the jet, and the pressure half time. By comparing the pre and post-operative
studies it was determined whether our technique reduced the severity of AR.
BetweenJune1992andApril1996,37patientsmedianage7.5years(range
0.5-36) underwentaubaorticmembraneresectionas partof the procedure.
Twenty-one patients raquired no other procedure though 6 were redos and
6 followed previous VSD closura. Five underwant concomitant VSD closure,
5 relief of .supravalvarstenosis, 5 aortic valve commissurotomy, 2 right ven-
tricular myomectomy,and 2 resection of accessory mitral valve tissue. Thare
was a significant reduction in left ventricular outflow gradlent from 65+30 to
15+ 12 mmHg (p= 0.001), and a significant improvement in tha severity of
AR (p =0.01) from mild/moderate to none/trivial post-operatively; 15 patients
showed improvement, 18 no change, and only 4 deterioration. By univartata
analysis, no associated lesion showed eignificence in influencing the sever-
i@rof AR postoperatively. In conclusion, radical resection of the aubvalvar
membrane combined with aggressive myomecfomy produces excellent M.
Iief of subaortic stenosis and frees the valve leaflets aignificently reducing
the associated AR.
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1751-61 Au9mentetionAorti~Va,vu,oP,aWforAortk
Insufficiencyin PediatricPatients
S. Sopontammarek, P.C.Smith, D.A. Roberson, R.A. Amilla, M.N. Ilbawi.
The Heart Institute for Children, University of Illinois, Oak Lawn, // 60463,
USA
Based on anatomic studies of congenitally abnormal aortlc valves, we
adopted a novel approach to surgical correction of aortic valve insufficiency
in pediatric patients. A glutaraldehyde-treated, autologoue pericardial patch
is tailored to fit the deficient segments of native valve leaflets. It ia aecured to
the free edge of the leaflet and euspended to the aortic wall at the commis-
sures, thus restoring sinus depth and facilitating leaflet coeptetion. The study
population included 12 patients, ages 4-18 yrs, with diagnoaes of bicuspid
aorlic valve with/without aottic valvotomy (9), VSD with aortic valve prolapse
(l), rheumatic fever (l), and truncus arteriosua (l). Transthoracic Doppler-
echocardiogrephy wee employed to quantify a ratio betwean the proximal
regurgitant jet diameter and the left ventricular outflow tract diameter (PJR),
left ventricular and diastolic diameter index (LVEDD), and tha Z-value of the
left ventricular and-diastolic voiume (ZLVEDV). Pre-operative PJR was 0.49
+ 0.02, LVEDD was 4.56 + 0.13 cm/M2, and ZLVEDV was 0.70 * 0.52
(IO pte),Intreoperative transesophageal Doppler-echocardiography (7 p,~)
revealed a poet-repair PJR of 0.22 + 0.01 (p < 0.02). Hoapitel stay was 4 +
1days with no early or late deaths and no thromboembolic events. Follow-up
at 9.5 (2–26) months yielded a PJR of 0.26 + 0.02 (p c 0.002), LVEDD of
4.26 & 0.20 cm/M2 (p= NS), and ZLVEDV of 0.24 + 0.52 (p = NS). Conc/u-
siom Augmentation aortic valvuloplaety is an alternative surgical approach to
aortic insufficiency in pedriatic patients improves valvar competence over the
intermediate term, avoids systemic anticoagulation, and preaetvee annular
growth potential. The reeults support early surgical intervention to prevent
progressive myocardial damage ceueed by untreated aortic insufficiency.
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~1 Strength,fati9ueandmasaofs~e,etalmuec,ein
chronicheartfailure;relationto measuresof
exercisecapacity
D. Barrington, S.D. Anker, P.A. Peale-Wilson, A.J.S. Coate. Nationa//-feart
andLungInst,London,UK
Aims:To define muscle function in CHF, evaluate the mechanism by which
any weakness occurs and explore the aaeociation between muscle function,
exercise cepacilyand theventilatory response toexemise. Me#rcds:98 CHF
patients and 32 controls were studied (all male), matched for age and BMI
(59.1 + 0.9S vs 58.5 + 1.7 y, 26.6 * 0.4 ve 26.3 * 0.7 kg/m2, both p =
NS). Quadriceps (q) maximal isokinetic etrength, fatigue (20 min repeated
contraction at 40% mexstrength, assessment of etrength incompletion) and
cross-sectional area ([CSA] CT-scan mid femur) were aseessed.
CHF Controls P.
Peak v02 1S.1+ 0.6 33.3 l 1.4 <0.0001
VWC02 dope 37.1 l 1.2 26.1 +0,7 <0.0001
q strength(N) 409+ 12 463 & t7 0.002
Fatigue(% of bassline max) 79* 1 93* 2 <0.0001
q CSA (cmz) 59.6+ 1.6 66. t + 2.1 0.0096
Strength/qCSA(N/cm2) 6.6* 0,1 7.5 * 0.3 OJJ04
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Results areshowninthetable.
OveralltherewerecorrelationsbetweenpeakV02 andstrength(r= O.46,
p < 0.0001),quadsCSA(r = 0.355,p = 0.0002)and20 minutefatigue(r=
0.4p < 0.001)andbetweentheVE/VC02slopeandstrength(r= 0.345,p <
0.0001)quadsCSA(r= 0.28,p =0.005)and20 minutefatigue(r= 0.25,p=
0.006).Cone/usiorrs.’CHFpatientsareweakbacauseofatrophyandreduced
strengthper unit muscle.The associationsbetweenoxygenconsumption,
thevenfilatotyresponseto exerciseandmuscleindicessuggesthatmuscle
abnorrhalitiesmodifyexercisecapacityin CHF.
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m7522 Relation Between Low-lntenaity Exerciae Capacity
and Quality of Life in Patienta With Mild to Moderate
Congestive Heatl Failure
D.Weilenmann,H.P.Brunner-iaRocca,B.LuII,M.Schlumpf,W,Kiowski,
F.Follath.Division of Cardiology Depatiment of Medicine, Univeraiiy
Hospital, Zudch, Swlt.zerland
Exercisecepacify(EC)is an acceptedprognosticfactorin patients(P)with
congestiveheartfailure(CHF).However,iksrelationto measuresof quelify
of life (QOL)suchas the “Minnesotalivingwithheartfailurequestionnaire”
(MC!)is IXJOrlydefined.Therefore,we repeatedlyassessedtheMQandlow-
intensityandmaximalECduringtreatmentwithdifferentdosesofenalaprilin
24P (age:52* 11years)with impairedsystolicleftventricularfunction(EF
=26 +6%) andmildto moderateCHF(NYHA:2.1*0.4). ECwasassessed
byasfendardprotocoltreadmillergospirometty(6minlow-intensityexercise
followedbya maximalexercisarampprotocol;peakoxygenuptake(pV02),
02-kinetics,totalexerciseduration(TED)).
NocorrelationwasfoundbetweenthetotalMQscore(SMQ)andpVOZ(r
= -0.11, ns).A moderatecorrelationexistedbetwaenSMQandTED(r= –
0.23,p < 0.05),whereasSMQandthe02-deficit(r= O.43,p < 0.001)aswell
asthe meanresponsetime(MRT[tvz of increasein 02-uptake];r = 0.46,p
< 0.001)weramoretightlylinkedduringIow-intansityexercise.NYHAclass
correlatedwithallparameters(bestwithSMQ:r =0.45,ps 0.001andlowest
withpV02:r= – 0.33,p < 0.006).
Conclusion: P do not seemto noticethe extentof impairmentin pVOZ
duringdaily life. In contrast,the Oz-deficitcorrelatedbetterwith the SMQ
indicatingthatincreasesof Iow-int.ensityexerciseperformanceareperceived
asbetterQOL.Ourdata,therefore,suppori the concept of using a submax-
imal stress test to evaluate the extent of impairment during daily life, and,
accordingly, measures of QOLin PwithCHF.
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m7523 Clinical Relevence of Arterial Oxygen Saturation
Instability to Detect Breathing Disorders in Chronic
Heart Failure
A. Mortara,G.D.Pinna,R.Maestri,A. Prpa,F.Cobelli,P.Sleight
L.Tavazzi.Division of Cardiology “S. Maugeri” Fourrdation, IRCCS,
Montescano, Pavia, Italx 1John Radcliffe Hospital, Oxford, UK
Recentlyit has been shownthat in chronicheartfailure (CHF),Cheyne-
Stokes(CS)respirationandperiodicbreathing(PB)arepresentduringboth
day-andnight-time.Thisalteredventilationisassociatedwithmarkedoscil-
lationsofarterialoxygensaturation(Sa02).Toaddresstherelationbetween
breathingdisordersandmodulationof Sa02 duringawakeday-time,80 pts
withmildto moderateCHF(age51 + 6 yra,LVEF27 * 6?’0,NYHAcl. I-ill,
stableoraltherapy)underwentsimultaneous20’ recordingsof instantaneous
lungvolume(ILV),beat-to-beatSa02 (earprobe)andheartrateat baselina
andduringcontrolledbreathing(12braathalmin).Analysisof ILVrevealeda
normalraspiratotypatternin 29 pts,while51 hada persistentalterationof
breathing,withatypicalCSin 21anda PBin 30.Overallvariabilityof Sa02
waeobtainadby analysieof thestandarddeviation(SD)of the beat-tobeat
signals.Sa02 wassignificantlyreducedin CSandPB(respectively,93.0*
1.8and 93.8 + 2% vs 94.2 + 1.6%,bothp c 0.02)and SDof Sa02 was
higher(1.5+ 0.6 and0.7+ 0.2%vs 0.4 * 0.1%,p <0.01 andp -=0.03)
as comparedto normals.ControlledventilationeliminatedCSand PBin all
patientswitha significantincreasein Sa02 (CS= +2.5%, p <0.001, PB=
+1.4%,p < 0.01);Sa02 variabilityremainedunchangedin normals,whileit
wasmarkedlyreducedin CSand PB(CS= 0.4 * 0.2%,PB= 0.3 + 0.2’%,
p <0.02 vs baseline).ByR.O.C.it wasfoundthat SDof Sa02 ?1% hada
sensitivityof 86Y0anda specificityof 100%in identifyingCHFpatients with
CS. Thus,in CHF,abnormalitiesof breathingactivitycausaa markedinsta-
bilityof Sa02 predisposingto prolongedperiodsof hypoxia.It is suggested
thatcontinuousbeat-to-beatanalysisof Sa02 andthesimplacalculationof
SDof themeanmaybea reliablemarkerforbreathingdisordersbothduring
dayandnightrecordings.
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Similar Efficacy (but Different Mechanism) on
Exercise CaDacltv of Losarten (LOS) and Enalanril
(EN) in Chronic Heert Failure (CHF) ““ ‘
M.Guazzi,P.G,Agostoni,G.C.Maranzi,G.Melzi,M.D.Guazzi.Urriversify
of Milan, C.N.R., Milan, Italy
Ameliorationof respiratoryfuncfionandexercisecapacifywithACE-inhibition
inCHFisantagonizedbyaspirin(AS),suggestinga bradykinin-prostaglandin
mediatedeffect.A comparativestudywith EN vs the ATI blocker,LOS,
aloneandin combinationwithAS, mayhelpto defineefficacyof one drug
ascomparedtotheother,selectivityof AScounteraction,roleof bradykinin-
prostaglandinactivation.16patientawithCHF(NYHAclassIll), treatadwith
digoxinandfurosemide,received(double-blind,randomorder),placebo(PL),
EN(20mg),AS(325mg),LOS(53mg),EN+AS,LOS+ASfor 15dayseach.
Lungdiffusioncapacity(DLCO,mmH~mirVkg),exercisetolerancetime(TT,
sac),vitalcapecify(VC,I)aswellaa oxygenuptake(V02P),deadspaca/tidal
volumeratio(VDiVp)at peakexerciseweretestedat theendof eachstep.
V02 p 1-r VDiVTP Vc DLCO
PL 15.7*3 572 + 181 0.21 +0.03 3.0 * 0,9 t9+3
EN 18* 4#~ 631 4154s$ 0.20+0.03 3.3 & 0.6 22 k4*5
EN+AS 16+4 590+ 130 0.22 +0.05 3,1 * 0.6 19*4
AS 15+5 579 * 133 0.19+0.05 3.0 * 0.9 le*6
LOS te 44*S 650 + 146#~ 0.19 l0.03$’5 3.0 + 1.0 20 i 3
LOS+AS 17+ 6#5 659 * 13#5 o.le + o.03#5 3.1 * 1.0 20*3
#p< 0.05 vs. PL; $ = p <0.05 vs. EN+AS. Mean valuss (+ 1 SD).
Conclusions.’ Effectivenessof the two drugson exercisecapacity(TT
andV02 p) is similarbutprobablymediatedthroughdifferentmechanisms,
as suggastedby a selectivecounteractionof AS againstEN.Prostglandin
activationoccurswith the ACE-inhibitorand not with the ATI blockerand
importantlyparticipatesin raisinglungdiffusionandfunctionalcapacity.im-
provementin TT andV02 p with LOSis dissociatedfrom significantinflu-
encesonthe respiratoryfunction.
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17’52-51Effects of L~aartanonExerc,ee CaPac,tY,MorbiditY
and Mortality in Patients with Symptomatic Heart
Failure
G.Klinger,N.Jaramillo,H. Ikram,M, Higginbctham,R.Lang,L).Kraus,
L.Washington,D.Sharma,W.Grossman.Merck& Co., /rrc., West Point,
PA, USA
Losartan(L) i$ a specificangiotenainII (Angll)fypa 1 receptorantagonist
whichblocksthe effectsof Angll generatadfrom bothACEand non-ACE
dependentpathways.Thus,LmayblocktheeffecfsofAngllmorecompletely
thananACEinhibitor.Twomulticenter,double-blind,placebc-controlled,ex-
ercisestudieswere parformedto assessthe efficacyand safetyof L in
patientswithheatifailure(HF).PatientswithNYHAClassII-IV HFandejec-
tionfractions40%wererandomizedin a 2:1 ratio(L:placebo[P]).Changes
in maximalexercisetime(ET-primatyendpoint)after12weeksof treatment
were not different between groups.Medianincreases(see)were55 and45
for L and P, respectively,in the U.S. studyand 90 and 100for L and P
in the Internationalstudy.However,eachstudyshowedfawardeathsand
hospitalizationsforHFduringtreatmentwithL (Table).A pre-specifiedmeta-
analysiscombiningthe2 studiesshoweda significantreductionindeathand
hospitalizationfor HFduringtreatmentwitht-.
US. (n =351) Int’1(n = 305) Combinsd
L P L P L P
Death 1.7% 3,5% 1,2%* 6,9% 1.4”/0” 5.3%
HF hospitalization 4,2% 6.6% 2,0% 5.3% 3.1”/&* 6.9”A
“ p <0,05 VS.pbo
Cone/usiorr:Comparedto placebo,treatmentwith losartanfor 12weeka
didnotimproveETbutaignificantlyraducedmorbidityandmortalityinpatienta
withheartfailure.
